Market Cap
$211.9M
PROF
Profound Medical Corp.
$5.84 ▼ -0.17%
Prev close $5.85Market cap$211.9M
12-mo target$11.14 (+90.8%)
High Impact Filing (7/10)3 New Institutional Positions3 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on PROF right now — valuation, ownership and activity at a glance.
Cap Size
Micro Cap
Inst. Holders
31 funds
Inst. Value
$36.3M
Inst. Activity
3 buys / 3 sells
SEC Reports
11
Press Releases
2
Price chart 30d -14.1%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 4, 2026 SEC Sep 3, 2026 SEC Aug 17, 2026 SEC Mar 5, 2026 Press
Profound Medical filed an 8-K announcing management will participate in the Lake Street Capital Markets BIG10 Conference
8-K — Impact 2/10
Profound Medical appointed Richard Fabian as President, effective September 1, 2026, succeeding Mathieu Burtnyk who move
8-K — Impact 3/10
Profound Medical announced the resignation of CFO Rashed Dewan and the appointment of Corporate Controller Matthew Sobcz
8-K — Impact 2/10
Aug 17, 2026 other
Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’
Most recent TDC software provides a potential roadmap for customers to easily achieve up to 6 TULSA
Jun 30, 2026 Inst.
First Eagle Investment Management, — ADD
440,207 shares ($2.9M)
Jun 30, 2026 Inst.
Apr 1, 2026 Press RAYMOND JAMES FINANCIAL INC — ADD
189,116 shares ($1.3M)
Profound Medical announced that its TULSA-PRO system and the MRI-guided TULSA Procedure will be featured in multiple pre
Impact 3/10
Profound Medical reported record Q4 and full-year 2025 results, with Q4 revenue up 43% YoY to $6.0 million, driven by st
Impact 6/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Jan 7, 2026 | Lake Street | MAINTAIN | Buy | 45% |
| Apr 23, 2025 | Lake Street | MAINTAIN | Buy | 45% |
| Jul 16, 2024 | Stifel | UPGRADE | Buy | 54% |
| Mar 11, 2024 | Alliance Global Partners | MAINTAIN | Buy | 42% |
| Mar 8, 2024 | Stifel | MAINTAIN | Hold | 54% |
| Jan 4, 2024 | Alliance Global Partners | MAINTAIN | Buy | 42% |
| Nov 28, 2023 | Stifel | INITIATE | Hold | 54% |
| Aug 4, 2023 | Raymond James | DOWNGRADE | Outperform | 54% |
| May 11, 2023 | TD Cowen | MAINTAIN | Outperform | 56% |
| May 11, 2023 | Alliance Global Partners | MAINTAIN | Buy | 42% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Aug 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Jul 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Jun 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| May 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Apr 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Mar 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Feb 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% |
Price targets
Where 5 covering analysts think PROF trades over the next 12 months.
$11.14 +90.8% upside Strong Buy
Current$5.84 Low$10.00 Median$11.20 High$12.00 5 analysts
$10.00$12.00
Analyst rating None as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
11 SEC filing reports analyzed · 2 bullish, 0 bearish, 0 mixed, 9 neutral · avg impact 3.4/10.Plus 2 press releases.
NEUTRAL8-K2/10
Profound Medical filed an 8-K announcing management will participate in the Lake Street Capital Mark
Sep 4, 2026
NEUTRAL8-K3/10
Profound Medical appointed Richard Fabian as President, effective September 1, 2026, succeeding Math
Sep 3, 2026
NEUTRAL8-K2/10
Profound Medical announced the resignation of CFO Rashed Dewan and the appointment of Corporate Cont
Aug 17, 2026
NEUTRAL8-K3/10
Profound Medical announced the introduction of its latest Treatment Delivery Console (TDC) software,
Aug 17, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 17, 2026
other
Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’
Most recent TDC software provides a potential roadmap for customers to easily achieve up to 6 TULSA Procedures™ per system per day Most recent TDC sof
Apr 14, 2026
other
Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
TORONTO, April 14, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=1aPABF3srsm7P_WvunU8RgC9Hyar8RG0I
Apr 1, 2026
fda
Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=MqKA1dSitc8sYXgush1gYudRJGgjMq7vT
Mar 27, 2026
other
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone
TORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=2sVO_sShLW1C8-p8jEb3KXUv3DvnplPd7
Mar 13, 2026
other
CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
– First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prosta
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.23 | $-0.25–$-0.21 | 12.5% | +6.2% | 3↑ 0↓ | $0.0B | 4 |
| Next Q | $-0.18 | $-0.19–$-0.18 | 31.5% | +14.9% | 3↑ 0↓ | $0.0B | 4 |
| Current FY | $-0.86 | $-0.89–$-0.84 | 38.8% | -2.2% | 3↑ 0↓ | $0.0B | 4 |
| Next FY | $-0.59 | $-0.77–$-0.07 | 31.8% | +21.8% | 2↑ 0↓ | $0.1B | 5 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.228 | — |
| 7d ago | $-0.242 | +0.015 |
| 30d ago | $-0.242 | +0.015 |
| 60d ago | $-0.242 | +0.015 |
| 90d ago | $-0.233 | +0.005 |
Institutional ownership
Which big funds own PROF (from quarterly 13F filings) and who is adding or trimming.
31 institutional holders with $36.3M total value (5,491,300 shares) as of 2026-Q2. Top holders: FIL, ROYCE, ROYAL.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| FIL Ltd | 2,370,000 | $15.8M | 43.4% | — |
| ROYCE & ASSOCIATES LP | 1,199,564 | $8.0M | 22.0% | ADD +34.3% |
| ROYAL BANK OF CANADA | 491,495 | $3.3M | 9.0% | — |
| First Eagle Investment Management, LLC | 440,207 | $2.9M | 8.1% | ADD +36.4% |
| RAYMOND JAMES FINANCIAL INC | 189,116 | $1.3M | 3.5% | ADD +25.9% |
| NATIONAL BANK OF CANADA /FI/ | 218,698 | $1.2M | 3.4% | — |
| TD Waterhouse Canada Inc. | 138,110 | $933.6K | 2.6% | ADD +84.6% |
| UBS Group AG | 55,224 | $367.2K | 1.0% | TRIM -31.9% |
| CITADEL ADVISORS LLC | 51,800 | $344.5K | 0.9% | NEAR_EXIT -78.2% |
| TRUIST FINANCIAL CORP | 50,000 | $332.5K | 0.9% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| First Eagle Investment Management, LLC | ADD | 322,707 | 440,207 | +36.4% | $2.9M |
| RAYMOND JAMES FINANCIAL INC | ADD | 150,157 | 189,116 | +25.9% | $1.3M |
| UBS Group AG | TRIM | 81,108 | 55,224 | -31.9% | $367.2K |
| MORGAN STANLEY | DOUBLED | 1,929 | 7,067 | +266.4% | $47.0K |
| WELLS FARGO & COMPANY/MN | TRIM | 5,592 | 4,006 | -28.4% | $26.6K |
| OSAIC HOLDINGS, INC. | TRIM | 3,075 | 1,275 | -58.5% | $8.5K |
| TD Waterhouse Canada Inc. | ADD | 77,493 | 143,041 | +84.6% | $902.0K |
| UBS Group AG | DOUBLED | 5,505 | 81,108 | +1373.4% | $525.6K |
| SIMPLEX TRADING, LLC | DOUBLED | 597 | 36,718 | +6050.4% | $237.9K |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | 14,049 | 21,346 | +51.9% | $138.3K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for PROF.
Shares short
1,571,427
Settlement Sep 15, 2026
Change vs prior
-3.0%
Semi-monthly cycle
Days to cover
12.3
At avg daily volume
Of shares outstanding
≈4.3%
Estimate — not % of float
All PROF filing & press-release reports (13)
- 8-K reportSep 4, 2026
- 8-K reportSep 3, 2026
- 8-K reportAug 17, 2026
- 8-K reportAug 17, 2026
- 8-K reportJul 24, 2026
- 8-K reportJul 15, 2026
- 8-K reportMay 14, 2026
- S-3 reportMay 12, 2026
- 8-K reportApr 16, 2026
- 8-K reportApr 14, 2026
- PRESS-RELEASE reportApr 1, 2026
- 8-K reportMar 5, 2026
- PRESS-RELEASE reportMar 5, 2026